Information  X 
Enter a valid email address

ICON plc (ICLR)

  Print      Mail a friend

Tuesday 22 July, 2008

ICON plc

AGM Statement

Icon PLC
                  

AGM of ICON plc Approves 'Stock Split'

ICON (NASDAQ:ICLR) (ISIN: IE0005711209), a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical device
industries, announced that at its Annual General Meeting held in Dublin
yesterday, all resolutions put to the meeting were passed. These included a
proposal for a bonus issue of one new ordinary share (or ADS) to the holder of
each existing ordinary share (or ADS), the effect of which will be the
equivalent of a two-for-one stock split.

Following the passing of this resolution, the issue of the new shares will be
made to the holders of record on August 8, 2008.

ICON is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. We specialize in
the strategic development, management and analysis of programs that support
clinical development - from compound selection to Phase I-IV clinical studies.
With headquarters in Dublin, Ireland, ICON currently operates from 71 locations
in 38 countries and has approximately 6,500 employees. Further information is
available at www.iconplc.com

The statements made in this Press Release may contain forward-looking statements
that involve a number of risks and uncertainties. In addition to the matters
described in this Press Release, the ability to maintain large client contracts
or enter into new contracts, maintain client relationships and the ability to
manage the opening of new offices, the integration of new business mergers and
acquisitions, as well as other risks and uncertainties detailed from time to
time in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3,
may affect the actual results achieved by ICON. ICON disclaims any intent or
obligation to update these forward-looking statements.

ICON
Investor Relations 1-888-381-7923
or
Ciaran Murray CFO + 353 -1-291-2000
                                                                                                       

a d v e r t i s e m e n t